Author:
Strano S,Dell'Orso S,Di Agostino S,Fontemaggi G,Sacchi A,Blandino G
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Genetics,Molecular Biology
Reference96 articles.
1. Aas T, Borrensen AL, Geisler S, Smith-Sorensen B, Johnsen H, Varhaug J et al. (1996). Specific p53 mutations are associated with de novo resistance to doxorubicin in breast cancer patients. Nat Med 2: 811–814.
2. Augustin M, Bamberger C, Paul D, Schmale H . (1998). Cloning and chromosomal mapping of the human p53 related KET gene to chromosome 3q27 and its murine homolog KET to mouse chromosome 16. Mamm Genome 9: 899–902.
3. Beinz B, Zacut-Houri R, Givol D, Oren M . (1984). Analysis of the gene coding for the murine cellular tumor antigen p53. EMBO J 3: 2179–2183.
4. Berns EM, Foekens JA, Vossen R, Look MP, Devilee P, Henzen-Logmans SC et al. (2000). Complete sequencing of TP53 predicts poor response to systemic therapy of advanced breast cancer. Cancer Res 60: 2155–2162.
5. Blandino G, Levine AJ, Oren M . (1999). Mutant p53 gain of function: differential effects of different p53 mutants on resistance of cultured cells on chemotherapy. Oncogene 18: 477–485.
Cited by
214 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献